Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. immune serum
Show results for

Companies

Articles
Downloads

Refine by
Date

  • Older

Immune Serum Articles & Analysis

5 articles found

Microarray Printing in Glycobiology Research: Advancements and Applications

Microarray Printing in Glycobiology Research: Advancements and Applications

For example, cancer cells often display altered glycosylation patterns on their surface, which can affect their ability to evade the immune system or metastasize. Glycan microarrays allow researchers to detect these changes and correlate them with disease stages or therapeutic responses, providing valuable tools for diagnostics and personalized medicine. 3. ...

ByCD BioGlyco.


FluGen Announces First Subject Dosed in Phase 1b Clinical Trial of its Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults

FluGen Announces First Subject Dosed in Phase 1b Clinical Trial of its Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults

The study will evaluate subjects’ ability to raise mucosal antibodies in the nasal passages, serum antibodies against matched and drifted strains of the influenza virus, and cellular immune responses. ...

ByFluGen, Inc.


FluGen Initiates NIH-Funded Trial of M2SR Flu Vaccine; First Study in Adults Up to Age 85

FluGen Initiates NIH-Funded Trial of M2SR Flu Vaccine; First Study in Adults Up to Age 85

Previous studies have also demonstrated that, unlike currently licensed influenza vaccines administered by intramuscular injection, intranasal M2SR stimulates mucosal and cellular immunity as well as serum humoral immunity. “Flu causes more serious illness, which results in a greater number of deaths in older adults, as compared to other ...

ByFluGen, Inc.


Overcoming Immunological Challenges Limiting Capsid-Mediated Gene Therapy With Machine Learning

Overcoming Immunological Challenges Limiting Capsid-Mediated Gene Therapy With Machine Learning

The challenges of evading both pre-existing immunity and de novo adaptive immune responses against AAV vectors are made especially difficult by the heterogeneous nature of patient immune responses and immune histories. ...

ByDyno Therapeutics


Immunity development following oral vaccination against Actinobacillus pleuropneumoniae in a mouse model

Immunity development following oral vaccination against Actinobacillus pleuropneumoniae in a mouse model

Experimental results reveal pronounced systemic immunity and serum antibodies in the group vaccinated by injection. The orally vaccinated group demonstrated more expressed local immunity and mucous antibodies than control group. ...

ByInderscience Publishers

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT